Global Microbiome Therapies Market Size, Status and Forecast 2024-2034
Global Microbiome Therapies Scope and Market Size
Microbiome Therapies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Microbiome Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Bacteria
Fungi
Virus
Others
Segment by Application
Testing Centres
Research Labs
Horticulture
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
uBiome
Evolve BioSystems
Indigo Agriculture
Pivot Bio
Concentric Ag
Epibiome
CosmosID
Human Longevity
Ajinomoto Cambrooke
AnimalBiome

Table of Content
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microbiome Therapies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bacteria
1.2.3 Fungi
1.2.4 Virus
1.2.5 Others
1.3 Market by Application
1.3.1 Global Microbiome Therapies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Testing Centres
1.3.3 Research Labs
1.3.4 Horticulture
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Microbiome Therapies Market Perspective (2016-2027)
2.2 Microbiome Therapies Growth Trends by Regions
2.2.1 Microbiome Therapies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Microbiome Therapies Historic Market Share by Regions (2016-2021)
2.2.3 Microbiome Therapies Forecasted Market Size by Regions (2022-2027)
2.3 Microbiome Therapies Industry Dynamic
2.3.1 Microbiome Therapies Market Trends
2.3.2 Microbiome Therapies Market Drivers
2.3.3 Microbiome Therapies Market Challenges
2.3.4 Microbiome Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microbiome Therapies Players by Revenue
3.1.1 Global Top Microbiome Therapies Players by Revenue (2016-2021)
3.1.2 Global Microbiome Therapies Revenue Market Share by Players (2016-2021)
3.2 Global Microbiome Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Microbiome Therapies Revenue
3.4 Global Microbiome Therapies Market Concentration Ratio
3.4.1 Global Microbiome Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microbiome Therapies Revenue in 2020
3.5 Microbiome Therapies Key Players Head office and Area Served
3.6 Key Players Microbiome Therapies Product Solution and Service
3.7 Date of Enter into Microbiome Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Microbiome Therapies Breakdown Data by Type
4.1 Global Microbiome Therapies Historic Market Size by Type (2016-2021)
4.2 Global Microbiome Therapies Forecasted Market Size by Type (2022-2027)
5 Microbiome Therapies Breakdown Data by Application
5.1 Global Microbiome Therapies Historic Market Size by Application (2016-2021)
5.2 Global Microbiome Therapies Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Microbiome Therapies Market Size (2016-2027)
6.2 North America Microbiome Therapies Market Size by Type
6.2.1 North America Microbiome Therapies Market Size by Type (2016-2021)
6.2.2 North America Microbiome Therapies Market Size by Type (2022-2027)
6.2.3 North America Microbiome Therapies Market Size by Type (2016-2027)
6.3 North America Microbiome Therapies Market Size by Application
6.3.1 North America Microbiome Therapies Market Size by Application (2016-2021)
6.3.2 North America Microbiome Therapies Market Size by Application (2022-2027)
6.3.3 North America Microbiome Therapies Market Size by Application (2016-2027)
6.4 North America Microbiome Therapies Market Size by Country
6.4.1 North America Microbiome Therapies Market Size by Country (2016-2021)
6.4.2 North America Microbiome Therapies Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Microbiome Therapies Market Size (2016-2027)
7.2 Europe Microbiome Therapies Market Size by Type
7.2.1 Europe Microbiome Therapies Market Size by Type (2016-2021)
7.2.2 Europe Microbiome Therapies Market Size by Type (2022-2027)
7.2.3 Europe Microbiome Therapies Market Size by Type (2016-2027)
7.3 Europe Microbiome Therapies Market Size by Application
7.3.1 Europe Microbiome Therapies Market Size by Application (2016-2021)
7.3.2 Europe Microbiome Therapies Market Size by Application (2022-2027)
7.3.3 Europe Microbiome Therapies Market Size by Application (2016-2027)
7.4 Europe Microbiome Therapies Market Size by Country
7.4.1 Europe Microbiome Therapies Market Size by Country (2016-2021)
7.4.2 Europe Microbiome Therapies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Microbiome Therapies Market Size (2016-2027)
8.2 Asia-Pacific Microbiome Therapies Market Size by Type
8.2.1 Asia-Pacific Microbiome Therapies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Microbiome Therapies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Microbiome Therapies Market Size by Type (2016-2027)
8.3 Asia-Pacific Microbiome Therapies Market Size by Application
8.3.1 Asia-Pacific Microbiome Therapies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Microbiome Therapies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Microbiome Therapies Market Size by Application (2016-2027)
8.4 Asia-Pacific Microbiome Therapies Market Size by Region
8.4.1 Asia-Pacific Microbiome Therapies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Microbiome Therapies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Microbiome Therapies Market Size (2016-2027)
9.2 Latin America Microbiome Therapies Market Size by Type
9.2.1 Latin America Microbiome Therapies Market Size by Type (2016-2021)
9.2.2 Latin America Microbiome Therapies Market Size by Type (2022-2027)
9.2.3 Latin America Microbiome Therapies Market Size by Type (2016-2027)
9.3 Latin America Microbiome Therapies Market Size by Application
9.3.1 Latin America Microbiome Therapies Market Size by Application (2016-2021)
9.3.2 Latin America Microbiome Therapies Market Size by Application (2022-2027)
9.3.3 Latin America Microbiome Therapies Market Size by Application (2016-2027)
9.4 Latin America Microbiome Therapies Market Size by Country
9.4.1 Latin America Microbiome Therapies Market Size by Country (2016-2021)
9.4.2 Latin America Microbiome Therapies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microbiome Therapies Market Size (2016-2027)
10.2 Middle East & Africa Microbiome Therapies Market Size by Type
10.2.1 Middle East & Africa Microbiome Therapies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Microbiome Therapies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Microbiome Therapies Market Size by Type (2016-2027)
10.3 Middle East & Africa Microbiome Therapies Market Size by Application
10.3.1 Middle East & Africa Microbiome Therapies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Microbiome Therapies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Microbiome Therapies Market Size by Application (2016-2027)
10.4 Middle East & Africa Microbiome Therapies Market Size by Country
10.4.1 Middle East & Africa Microbiome Therapies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Microbiome Therapies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 uBiome
11.1.1 uBiome Company Details
11.1.2 uBiome Business Overview
11.1.3 uBiome Microbiome Therapies Introduction
11.1.4 uBiome Revenue in Microbiome Therapies Business (2016-2021)
11.1.5 uBiome Recent Development
11.2 Evolve BioSystems
11.2.1 Evolve BioSystems Company Details
11.2.2 Evolve BioSystems Business Overview
11.2.3 Evolve BioSystems Microbiome Therapies Introduction
11.2.4 Evolve BioSystems Revenue in Microbiome Therapies Business (2016-2021)
11.2.5 Evolve BioSystems Recent Development
11.3 Indigo Agriculture
11.3.1 Indigo Agriculture Company Details
11.3.2 Indigo Agriculture Business Overview
11.3.3 Indigo Agriculture Microbiome Therapies Introduction
11.3.4 Indigo Agriculture Revenue in Microbiome Therapies Business (2016-2021)
11.3.5 Indigo Agriculture Recent Development
11.4 Pivot Bio
11.4.1 Pivot Bio Company Details
11.4.2 Pivot Bio Business Overview
11.4.3 Pivot Bio Microbiome Therapies Introduction
11.4.4 Pivot Bio Revenue in Microbiome Therapies Business (2016-2021)
11.4.5 Pivot Bio Recent Development
11.5 Concentric Ag
11.5.1 Concentric Ag Company Details
11.5.2 Concentric Ag Business Overview
11.5.3 Concentric Ag Microbiome Therapies Introduction
11.5.4 Concentric Ag Revenue in Microbiome Therapies Business (2016-2021)
11.5.5 Concentric Ag Recent Development
11.6 Epibiome
11.6.1 Epibiome Company Details
11.6.2 Epibiome Business Overview
11.6.3 Epibiome Microbiome Therapies Introduction
11.6.4 Epibiome Revenue in Microbiome Therapies Business (2016-2021)
11.6.5 Epibiome Recent Development
11.7 CosmosID
11.7.1 CosmosID Company Details
11.7.2 CosmosID Business Overview
11.7.3 CosmosID Microbiome Therapies Introduction
11.7.4 CosmosID Revenue in Microbiome Therapies Business (2016-2021)
11.7.5 CosmosID Recent Development
11.8 Human Longevity
11.8.1 Human Longevity Company Details
11.8.2 Human Longevity Business Overview
11.8.3 Human Longevity Microbiome Therapies Introduction
11.8.4 Human Longevity Revenue in Microbiome Therapies Business (2016-2021)
11.8.5 Human Longevity Recent Development
11.9 Ajinomoto Cambrooke
11.9.1 Ajinomoto Cambrooke Company Details
11.9.2 Ajinomoto Cambrooke Business Overview
11.9.3 Ajinomoto Cambrooke Microbiome Therapies Introduction
11.9.4 Ajinomoto Cambrooke Revenue in Microbiome Therapies Business (2016-2021)
11.9.5 Ajinomoto Cambrooke Recent Development
11.10 AnimalBiome
11.10.1 AnimalBiome Company Details
11.10.2 AnimalBiome Business Overview
11.10.3 AnimalBiome Microbiome Therapies Introduction
11.10.4 AnimalBiome Revenue in Microbiome Therapies Business (2016-2021)
11.10.5 AnimalBiome Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details